Ke‐Ping Shen

517 total citations
21 papers, 417 citations indexed

About

Ke‐Ping Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ke‐Ping Shen has authored 21 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Ke‐Ping Shen's work include Traditional Chinese Medicine Analysis (5 papers), Natural product bioactivities and synthesis (3 papers) and Cancer-related Molecular Pathways (3 papers). Ke‐Ping Shen is often cited by papers focused on Traditional Chinese Medicine Analysis (5 papers), Natural product bioactivities and synthesis (3 papers) and Cancer-related Molecular Pathways (3 papers). Ke‐Ping Shen collaborates with scholars based in China, Hong Kong and United States. Ke‐Ping Shen's co-authors include Hong‐Mei An, Shan Deng, Mengmeng Wei, Bing Hu, Bing Hu, Ling Xu, Ling Xu, Qin Du, Yang Wu and Shuangshuang Wang and has published in prestigious journals such as Frontiers in Pharmacology, Frontiers in Oncology and BMC Complementary and Alternative Medicine.

In The Last Decade

Ke‐Ping Shen

21 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke‐Ping Shen China 12 208 85 68 65 55 21 417
Zhangfeng Zhong China 13 330 1.6× 58 0.7× 55 0.8× 82 1.3× 63 1.1× 19 536
Chun-Shu Yu Taiwan 14 362 1.7× 99 1.2× 70 1.0× 37 0.6× 51 0.9× 17 559
Chao‐Ying Lee Taiwan 10 263 1.3× 104 1.2× 56 0.8× 64 1.0× 59 1.1× 13 521
Muthi Ikawati Indonesia 13 215 1.0× 74 0.9× 52 0.8× 54 0.8× 61 1.1× 59 453
Ching-Lung Liao Taiwan 13 284 1.4× 83 1.0× 76 1.1× 45 0.7× 98 1.8× 14 506
Shu Chun Hsu Taiwan 12 351 1.7× 81 1.0× 60 0.9× 55 0.8× 95 1.7× 14 556
Rafiq A. Rather India 9 217 1.0× 45 0.5× 70 1.0× 30 0.5× 41 0.7× 11 495
Yi‐Shih Ma Taiwan 15 321 1.5× 119 1.4× 61 0.9× 32 0.5× 106 1.9× 24 565
Zongping Zhu China 11 283 1.4× 114 1.3× 43 0.6× 62 1.0× 51 0.9× 17 562
Nidarshana Chaturvedi Parashar India 13 335 1.6× 84 1.0× 52 0.8× 31 0.5× 87 1.6× 23 552

Countries citing papers authored by Ke‐Ping Shen

Since Specialization
Citations

This map shows the geographic impact of Ke‐Ping Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke‐Ping Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke‐Ping Shen more than expected).

Fields of papers citing papers by Ke‐Ping Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke‐Ping Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke‐Ping Shen. The network helps show where Ke‐Ping Shen may publish in the future.

Co-authorship network of co-authors of Ke‐Ping Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ke‐Ping Shen. A scholar is included among the top collaborators of Ke‐Ping Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke‐Ping Shen. Ke‐Ping Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shuangshuang, Ke‐Ping Shen, Lei Chen, et al.. (2021). Ursolic acid induces apoptosis and anoikis in colorectal carcinoma RKO cells. BMC Complementary Medicine and Therapies. 21(1). 52–52. 22 indexed citations
4.
Xia, Yan, Miao Li, Lei Chen, et al.. (2020). α‑Solanine inhibits growth and metastatic potential of human colorectal cancer cells. Oncology Reports. 43(5). 1387–1396. 23 indexed citations
5.
Wang, Shuangshuang, Ke‐Ping Shen, Xiaowei Huang, et al.. (2020). Ursolic acid potentiated oxaliplatin to induce apoptosis in colorectal cancer RKO cells.. PubMed. 75(6). 246–249. 14 indexed citations
6.
Mao, Zhu-Jun, et al.. (2019). Comparisons of Cardiotoxicity and Efficacy of Anthracycline-Based Therapies in Breast Cancer: A Network Meta-Analysis of Randomized Clinical Trials. Oncology Research and Treatment. 42(7-8). 405–413. 25 indexed citations
7.
Yu, Xiaoyan, Yang Bi, Yan Lu, et al.. (2016). Activation of phenylpropanoid pathway and PR of potato tuber against Fusarium sulphureum by fungal elicitor from Trichothecium roseum. World Journal of Microbiology and Biotechnology. 32(9). 142–142. 25 indexed citations
8.
Tang, Yamei, Huali Xue, Yang Bi, et al.. (2014). A method of analysis for T-2 toxin and neosolaniol by UPLC-MS/MS in apple fruit inoculated withTrichothecium roseum. Food Additives & Contaminants Part A. 32(4). 480–487. 32 indexed citations
9.
Hu, Bing, Qin Du, Shan Deng, et al.. (2014). Ligustrum lucidum Ait. fruit extract induces apoptosis and cell senescence in human hepatocellular carcinoma cells through upregulation of p21. Oncology Reports. 32(3). 1037–1042. 46 indexed citations
10.
Deng, Shan, Bing Hu, Hong‐Mei An, et al.. (2013). Teng-Long-Bu-Zhong-Tang, a Chinese herbal formula, enhances anticancer effects of 5 - Fluorouracil in CT26 colon carcinoma. BMC Complementary and Alternative Medicine. 13(1). 128–128. 37 indexed citations
11.
Hu, Bing, Hong‐Mei An, Ke‐Ping Shen, et al.. (2013). Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncology Reports. 29(5). 1851–1858. 98 indexed citations
12.
Hu, Bing, et al.. (2013). [Effect of Solanum nigrum on human colon carcinoma RKO cells ].. PubMed. 36(6). 958–61. 6 indexed citations
13.
Hu, Bing, Ke‐Ping Shen, Ling Xu, & Shan Deng. (2012). Inflammation, macrophage in cancer progression and chinese herbal treatment. PubMed. 3(2). 269–269. 11 indexed citations
14.
Hu, Bing, Ke‐Ping Shen, Hong‐Mei An, Yang Wu, & Qin Du. (2011). Aqueous Extract of Curcuma aromatica Induces Apoptosis and G2/M Arrest in Human Colon Carcinoma LS-174-T Cells Independent of p53. Cancer Biotherapy and Radiopharmaceuticals. 26(1). 97–104. 25 indexed citations
15.
Hu, Bing, Hong‐Mei An, Ke‐Ping Shen, et al.. (2011). Liver Yin deficiency tonifying herbal extract induces apoptosis and cell senescence in Bel-7402 human hepatocarcinoma cells. Experimental and Therapeutic Medicine. 3(1). 80–86. 10 indexed citations
16.
Shen, Ke‐Ping. (2010). Compatibility of Chinese Anti-cancer Herb. Zhongguo shiyan fangjixue zazhi. 3 indexed citations
17.
Shen, Ke‐Ping. (2009). Effects of"Weichang'an Decotion"on Growth,Metastasis and Angiogenesis of Gastric Cancer and MMP2 Expression. 1 indexed citations
18.
Hu, Bing, Hong‐Mei An, & Ke‐Ping Shen. (2009). Low dose of etoposide induces cell senescence in colon carcinoma.. Tumori. 29(8). 711–714. 1 indexed citations
19.
Shen, Ke‐Ping. (2008). Clinical Research of Curative Effect of Malignant Partial Intestinal Obstruction Treated with Anus Catheter Infusion of Herbs plus Chemotherapy. Shanghai Journal of Traditional Chinese Medicine. 1 indexed citations
20.
Shen, Ke‐Ping, et al.. (2003). [Clinical study on post-operative metastasis prevention of progressive stage of gastric cancer by weichang'an].. PubMed. 23(8). 580–2. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026